Cholesterol drug ‘slows progression of eye disease in people with diabetes’

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} A cholesterol-lowering drug may slow the progression of eye disease in people with diabetes, new research suggests. Diabetes can cause damage to the small blood vessels at the back of the eye, a condition called diabetic retinopathy which is among the top five causes of sight loss across the world. We’re excited by the positive results from this major trial of a new treatment to slow progression of eye damage, which has the potential to benefit many people with diabetes in the UK Dr Lucy Chambers Experts suggest the findings have the potential to benefit many people in the UK. “We’re excited by the positive results from this major trial of a new treatment to slow progression of eye damage, which has the potential to benefit many people with diabetes in the UK.” Dr David Preiss, Associate Professor at Oxford Population Health and lead author of the study, said: “Diabetic retinopathy remains a leading cause of visual loss.